Business
Director/PDMR shareholding
Director/PDMR shareholding.
About this update from Cellbxhealth Plc
[{"type":"text","content":"\n \n \n \n \n \n \n \n \n 09\n \n \n February 2023\n \n \n \n \n \n \n \n \n \n For immediate release\n \n \n \n \n \n \n \n \n \n ANGLE plc (\"the Company\")\n \n \n \n \n \n \n \n \n \n Director/PDMR shareholding\n \n \n \n \n \n \n \n \n ANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading\n liquid biopsy company,\n announces that, on 09 February 2023, it has been notified that Andrew Newland, Chief Executive Officer, purchased 125,000 ordinary shares of 10 pence each (\"Ordinary Shares\") at a price of 28.75 pence each. \n \n \n \n \n \n The Company was also notified that Ian Griffiths, Finance Director, purchased 30,000 Ordinary Shares via his self-invested personal pension (SIPP) at 29.175 pence each. Ian Griffiths also sold from his personal dealing account and re-purchased into his SIPP 37,500 Ordinary Shares at a price of 29.25 pence and 29.50 pence respectively.\n \n \n \n \n \n Further details are set out below:\n \n \n \n \n \n \n \n \n \n \n 1.\n \n \n \n \n \n \n Details of the person discharging managerial responsibilities/person closely associated\n \n \n \n \n \n \n \n \n (a)\n \n \n \n \n \n \n Name\n \n \n \n \n \n Andrew Newland\n \n \n \n \n \n \n \n 2.\n \n \n \n \n \n \n Reason for the notification\n \n \n \n \n \n \n \n \n (a)\n \n \n \n \n \n \n Position/status\n \n \n \n \n \n Chief Executive Officer\n \n \n \n \n \n \n \n (b)\n \n \n \n \n \n \n Initial notification/ Amendment\n \n \n \n \n \n Initial notification\n \n \n \n \n \n \n \n 3.\n \n \n \n \n \n \n Details of the issuer\n \n \n \n \n \n \n \n \n (a)\n \n \n \n \n \n \n Name\n \n \n \n \n \n ANGLE plc\n \n \n \n \n \n \n \n (b)\n \n \n \n \n \n \n LEI\n \n \n \n \n \n 213800BY11K6W3NMS374\n \n \n \n \n \n \n \n 4.\n \n \n \n \n \n \n Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted\n \n \n \n \n \n \n \n \n (a)\n \n \n \n \n \n \n Description of the Financial Instrument\n \n \n \n \n \n Ordinary shares of 10 pence each\n \n \n \n \n \n \n \n (b)\n \n \n \n \n \n \n Identification code of the Financial Instrument\n \n \n \n \n \n ISIN: GB0034330679\n \n \n \n \n \n \n \n (c)\n \n \n \n \n \n \n Nature of the transaction\n \n \n \n \n \n Acquisition of...